GlassScriptPhysician profile
Elliot L Servais
NPI 1194982421
$689,390.09
in general payments reported to CMS, 2019-2025
9 companies · $81K in 2025
The $81K reported for 2025 was more than what 98% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $25K · 2021: $172K · 2022: $104K · 2023: $137K · 2024: $148K · 2025: $81K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $215K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $103K · Travel and Lodging: $27K · Consulting Fee: $12K · Food and Beverage: $8,106 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $214,867.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $103,112.50 |
| Travel and Lodging | $27,171.35 |
| Consulting Fee | $11,939.50 |
| Food and Beverage | $8,106.08 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $675,835.61 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Astrazeneca Pharmaceuticals LP | $6,292.91 | 2023-2025 | Imfinzi |
| Conmed Corporation | $6,000.00 | 2023 | Airseal |
| Covidien LP | $465.00 | 2020 | |
| Astrazeneca Uk Limited | $416.74 | 2025 | |
| Boston Scientific Corporation | $200.00 | 2021 | |
| Ethicon INC. | $136.35 | 2020-2021 | |
| Siemens Medical Solutions USA, INC. | $43.48 | 2024 | Cios Spin |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliot Servais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.